Ibex Biosciences

Developer of antibody and gene therapy technologies for oncology, inflammation, autoimmune disease and retinal disease

placeCumberland, Maryland, United States calendar_todayFounded 2015 groups11 employees language ibex.bio

Innovation

4 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 234 times.

YearFilings
20191
20202
20213
20223
20233
20243
20254

Social engagement

Social engagement: 1.5K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

5 Mar 2026
Event
Investing in Healthcare panel
Coming soon